The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update

被引:0
|
作者
Rakotoarivelo, Volatiana [1 ,2 ]
Mayer, Thomas Z. [1 ,2 ,3 ,4 ]
Simard, Melissa [1 ,2 ]
Flamand, Nicolas [1 ,2 ]
Di Marzo, Vincenzo [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Laval, Ctr Rech Inst, Dept Med, Univ Cardiol & Pneumol Quebec, Quebec City, PQ G1V 4G5, Canada
[2] Univ Laval, Canada Excellence Res Chair Microbiome Endocannabi, Quebec City, PQ G1V 0V6, Canada
[3] Univ Laval, Ecole Nutr, Inst Nutr & Aliments Fonct, Quebec City, PQ G1V 0V6, Canada
[4] Univ Laval, Ecole Nutr, Ctr NUTRISS, Quebec City, PQ G1V 0V6, Canada
[5] Joint Int Unit CNR Italy & Univ Laval, Chem & Biomol Res Microbiome & Its Impact Metab H, Quebec City, PQ G1V 0V6, Canada
来源
MOLECULES | 2024年 / 29卷 / 14期
基金
加拿大健康研究院;
关键词
inflammatory diseases; inflammation; cannabinoid; endocannabinoid; cannabinoid receptor; ACID AMIDE HYDROLASE; ENDOGENOUS LIGAND 2-ARACHIDONOYLGLYCEROL; MONOGLYCERIDE LIPASE DEFICIENCY; INNATE LYMPHOID-CELLS; FATTY LIVER-DISEASE; TYPE-2; RECEPTOR; MURINE MODEL; ENDOCANNABINOID SYSTEM; EXPERIMENTAL COLITIS; NOLADIN ETHER;
D O I
10.3390/molecules29143381
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The emergence of inflammatory diseases is a heavy burden on modern societies. Cannabis has been used for several millennia to treat inflammatory disorders such as rheumatism or gout. Since the characterization of cannabinoid receptors, CB1 and CB2, the potential of cannabinoid pharmacotherapy in inflammatory conditions has received great interest. Several studies have identified the importance of these receptors in immune cell migration and in the production of inflammatory mediators. As the presence of the CB2 receptor was documented to be more predominant in immune cells, several pharmacological agonists and antagonists have been designed to treat inflammation. To better define the potential of the CB2 receptor, three online databases, PubMed, Google Scholar and clinicaltrial.gov, were searched without language restriction. The full texts of articles presenting data on the endocannabinoid system, the CB2 receptor and its role in modulating inflammation in vitro, in animal models and in the context of clinical trials were reviewed. Finally, we discuss the clinical potential of the latest cannabinoid-based therapies in inflammatory diseases.
引用
收藏
页数:36
相关论文
共 50 条
  • [21] Cholesterol as a modulator of cannabinoid receptor CB2 signaling
    Alexei Yeliseev
    Malliga R. Iyer
    Thomas T. Joseph
    Nathan J. Coffey
    Resat Cinar
    Lioudmila Zoubak
    George Kunos
    Klaus Gawrisch
    [J]. Scientific Reports, 11
  • [22] Crystal Structure of the Human Cannabinoid Receptor CB2
    Li, Xiaoting
    Hua, Tian
    Vemuri, Kiran
    Ho, Jo-Hao
    Wu, Yiran
    Wu, Lijie
    Popov, Petr
    Benchama, Othman
    Zvonok, Nikolai
    Locke, K'ara
    Qu, Lu
    Han, Gye Won
    Iyer, Malliga R.
    Cinar, Resat
    Coffey, Nathan J.
    Wang, Jingjing
    Wu, Meng
    Katritch, Vsevolod
    Zhao, Suwen
    Kunos, George
    Bohn, Laura M.
    Makriyannis, Alexandros
    Stevens, Raymond C.
    Liu, Zhi-Jie
    [J]. CELL, 2019, 176 (03) : 459 - +
  • [23] Targeting the cannabinoid CB2 receptor:: Mutations, modeling and development of CB2 selective ligands
    Raitio, KH
    Salo, OMH
    Nevalainen, T
    Poso, A
    Järvinen, T
    [J]. CURRENT MEDICINAL CHEMISTRY, 2005, 12 (10) : 1217 - 1237
  • [24] Antifibrogenic role of the cannabinoid receptor CB2 in the liver
    Julien, B
    Grenard, P
    Teixeira-Clerc, F
    Van Nhieu, JT
    Li, LY
    Karsak, M
    Zimmer, A
    Mallat, A
    Lotersztajn, S
    [J]. GASTROENTEROLOGY, 2005, 128 (03) : 742 - 755
  • [25] CB2 cannabinoid receptor induction in experimental stroke
    Jin, KL
    Mao, XO
    Goldsmith, PC
    Greenberg, DA
    [J]. ANNALS OF NEUROLOGY, 2000, 48 (02) : 257 - 261
  • [26] Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
    Nevalainen, Tapio
    [J]. CURRENT MEDICINAL CHEMISTRY, 2014, 21 (02) : 187 - 203
  • [27] Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor
    Patel, Monica
    Grimsey, Natasha L.
    Banister, Samuel D.
    Finlay, David B.
    Glass, Michelle
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (06):
  • [28] CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain
    Clayton, N
    Marshall, FH
    Bountra, C
    O'Shaughnessy, CT
    [J]. PAIN, 2002, 96 (03) : 253 - 260
  • [29] The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists
    Whiteside, G. T.
    Lee, G. P.
    Valenzano, K. J.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2007, 14 (08) : 917 - 936
  • [30] Peripheral cannabinoid receptor, CB2, regulates bone mass
    Ofek, O
    Karsak, M
    Leclerc, N
    Fogel, M
    Frenkel, B
    Wright, K
    Tam, J
    Attar-Namdar, M
    Kram, V
    Shohami, E
    Mechoulam, R
    Zimmer, A
    Bab, I
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (03) : 696 - 701